- Home
- NRXS vs PCM Comparison
NRXS vs PCM Comparison
Compare NRXS & PCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | NRXS | PCM |
|---|---|---|
| Founded | 2011 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Trusts Except Educational Religious and Charitable |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.9M | 66.8M |
| IPO Year | 2023 | 1994 |
Fundamental Metrics
Financial Performance| Metric | NRXS | PCM |
|---|---|---|
| Price | $7.31 | $4.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $13.00 | N/A |
| AVG Volume (30 Days) | ★ 120.5K | 89.8K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.68% |
| EPS Growth | ★ 22.13 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,569,282.00 | N/A |
| Revenue This Year | $172.91 | N/A |
| Revenue Next Year | $115.71 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 32.89 | N/A |
| 52 Week Low | $2.21 | $4.95 |
| 52 Week High | $9.33 | $6.76 |
Technical Indicators
Market Signals| Indicator | NRXS | PCM |
|---|---|---|
| Relative Strength Index (RSI) | 64.73 | 24.02 |
| Support Level | $7.17 | $4.95 |
| Resistance Level | $7.62 | $5.83 |
| Average True Range (ATR) | 0.39 | 0.08 |
| MACD | 0.20 | -0.01 |
| Stochastic Oscillator | 71.64 | 21.95 |
Price Performance
Historical ComparisonAbout NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
About PCM PCM Fund Inc.
Pcm Fund Inc is a closed-end investment management company. Its investment objective is to seek current income as a primary focus and also capital appreciation. The Fund invests in agency-guaranteed mortgage-backed securities, private-label mortgage-backed securities, high-yield corporate debt securities, and commercial mortgage-backed securities.